Celyad Oncology SA (CLYYF)

0.245 0.00 (0.00%) USD  |  OTCM  |  Nov 22, 16:00
More

Celyad Oncology Shareholders Equity (Quarterly): 1.107M for June 30, 2023

Shareholders Equity (Quarterly) Chart

Historical Shareholders Equity (Quarterly) Data

View and export this data back to 2012. Upgrade now.
Date Value
June 30, 2023 1.107M
June 30, 2022 32.02M
March 31, 2022 40.73M
December 31, 2021 49.41M
September 30, 2021 22.09M
June 30, 2021 29.59M
March 31, 2021 29.68M
December 31, 2020 38.12M
June 30, 2020 34.10M
December 31, 2019 51.10M
June 30, 2019 46.52M
June 30, 2019 46.52M
December 31, 2018 63.59M
June 30, 2018 84.04M
June 30, 2018 84.04M
December 31, 2017 57.03M
Date Value
June 30, 2017 88.37M
June 30, 2017 88.37M
December 31, 2016 96.08M
June 30, 2016 107.48M
June 30, 2016 107.48M
December 31, 2015 121.87M
June 30, 2015 140.07M
June 30, 2015 140.07M
December 31, 2014 32.45M
June 30, 2014 48.67M
June 30, 2014 48.67M
December 31, 2013 23.33M
June 30, 2013 -1.462M
June 30, 2013 -1.462M
December 31, 2012 -2.989M

Shareholders' Equity Definition

Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.

Read full definition.

Shareholders Equity (Quarterly) Range, Past 5 Years

1.107M
Minimum
Jun 2023
51.10M
Maximum
Dec 2019
32.79M
Average
33.06M
Median

Shareholders Equity (Quarterly) Benchmarks

Galapagos NV 3.197B
UCB SA 9.597B
Mithra Pharmaceuticals SA -9.487M
Nyxoah SA 116.95M
MDxHealth SA 16.99M

Shareholders Equity (Quarterly) Related Metrics

Total Assets (Quarterly) 13.23M
Total Liabilities (Quarterly) 12.13M
Current Ratio 1.263
Net Debt Paydown Yield 1.18%